Skip to main content
Recall Canary
Minocycline Hydrochloride 115 mg Tablets
← Back to all recalls
DRUG RECALLMODERATE

Minocycline Hydrochloride 115 mg Tablets

Ascend Laboratories is recalling Minocycline Hydrochloride 115 mg tablets due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist regarding alternative treatment options. Do not discontinue use of this medication without consulting a medical professional.

Recalled
Listed
Updated
Recall No.
D-0597-2026
Agency
FDA
Firm
Ascend Laboratories, LLC
Recall ID
99129
Status
ONGOING

Why it was recalled

Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets due to failed dissolution specifications. An out-of-specification result was observed during the 9th month of stability testing.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Minocycline Hydrochloride Extended-Release Tablets, USP

Lot code
25141635, 2028
Strength
115 mg
UPC
25141635

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Dissolution Failure recalls

Other recent recalls from Ascend Laboratories, LLC

All recalls from Ascend Laboratories, LLC

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-18 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification